Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-08-25

Clinical Trial Update: Durolane Versus Methylprednisolone in Knee Osteoarthritis [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Durolane to methylprednisolone for knee osteoarthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Durolane
  • METHYLPREDNISOLONE (methylprednisolone)

Snippet

Sponsor: Galderma R&D | Conditions: Knee Osteoarthritis | Phase 3 | Status: COMPLETED